HR of FISH and other technique subgroups in 7 studies (8 cohorts) displayed a poor prognosis of high MYC expression in breast cancer patients, however, the technique of IHC and Genechip (5 studies/ 8 cohorts) showed a negative prognosis of MYC overexpression. The gene discussed is MYC; the disease is breast carcinoma.